Français
ItalianoBond Travere Therapeutics Inc 2.5% ( US761299AB20 ) in USD
| Issuer | Travere Therapeutics Inc | ||||||||||||
| Market price | 98.75 % ▼ | ||||||||||||
| Country |  United States
|
||||||||||||
| ISIN code |
 US761299AB20 ( in USD )
|
||||||||||||
| Interest rate | 2.5% per year ( payment 2 times a year) | ||||||||||||
| Maturity | 14/09/2025 - Bond has expired | ||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||
| Minimal amount | / | ||||||||||||
| Total amount | 276 000 000 USD | ||||||||||||
| Cusip | 761299AB2 | ||||||||||||
| Detailed description |
Travere Therapeutics is a biopharmaceutical company focused on the development and commercialization of therapies for diseases affecting the kidneys and related areas. The Bond issued by Travere Therapeutics Inc ( United States ) , in USD, with the ISIN code US761299AB20, pays a coupon of 2.5% per year. The coupons are paid 2 times per year and the Bond maturity is 14/09/2025 |
||||||||||||
| |||||||||||||